GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Colinz Laboratories Ltd (BOM:531210) » Definitions » Cyclically Adjusted PS Ratio

Colinz Laboratories (BOM:531210) Cyclically Adjusted PS Ratio : 1.79 (As of Jun. 10, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Colinz Laboratories Cyclically Adjusted PS Ratio?

As of today (2024-06-10), Colinz Laboratories's current share price is ₹42.47. Colinz Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₹23.77. Colinz Laboratories's Cyclically Adjusted PS Ratio for today is 1.79.

The historical rank and industry rank for Colinz Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:531210' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.36   Med: 1.59   Max: 2.61
Current: 1.79

During the past years, Colinz Laboratories's highest Cyclically Adjusted PS Ratio was 2.61. The lowest was 0.36. And the median was 1.59.

BOM:531210's Cyclically Adjusted PS Ratio is ranked better than
56.53% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs BOM:531210: 1.79

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Colinz Laboratories's adjusted revenue per share data for the three months ended in Mar. 2024 was ₹6.471. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹23.77 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Colinz Laboratories Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Colinz Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Colinz Laboratories Cyclically Adjusted PS Ratio Chart

Colinz Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.36 1.10 1.54 1.58

Colinz Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.91 1.54 1.51 1.68 1.58

Competitive Comparison of Colinz Laboratories's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Colinz Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Colinz Laboratories's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Colinz Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Colinz Laboratories's Cyclically Adjusted PS Ratio falls into.



Colinz Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Colinz Laboratories's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=42.47/23.77
=1.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Colinz Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Colinz Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.471/153.0345*153.0345
=6.471

Current CPI (Mar. 2024) = 153.0345.

Colinz Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 3.933 91.425 6.583
201406 4.708 94.103 7.656
201409 4.757 96.780 7.522
201412 4.054 96.780 6.410
201503 3.732 97.163 5.878
201506 5.275 99.841 8.085
201509 4.298 101.753 6.464
201512 4.119 102.901 6.126
201603 4.018 102.518 5.998
201606 4.909 105.961 7.090
201609 4.892 105.961 7.065
201612 4.242 105.196 6.171
201703 3.731 105.196 5.428
201706 4.068 107.109 5.812
201709 4.981 109.021 6.992
201712 4.259 109.404 5.958
201803 4.102 109.786 5.718
201806 4.561 111.317 6.270
201809 4.367 115.142 5.804
201812 4.151 115.142 5.517
201903 3.697 118.202 4.786
201906 4.429 120.880 5.607
201909 4.360 123.175 5.417
201912 4.224 126.235 5.121
202003 3.620 124.705 4.442
202006 3.097 127.000 3.732
202009 3.518 130.118 4.138
202012 3.277 130.889 3.831
202103 3.581 131.771 4.159
202106 3.942 134.084 4.499
202109 4.268 135.847 4.808
202112 3.532 138.161 3.912
202203 3.338 138.822 3.680
202206 7.332 142.347 7.882
202209 7.560 144.661 7.998
202212 6.713 145.763 7.048
202303 6.864 146.865 7.152
202306 7.522 150.280 7.660
202312 6.774 152.924 6.779
202403 6.471 153.035 6.471

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Colinz Laboratories  (BOM:531210) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Colinz Laboratories Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Colinz Laboratories's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Colinz Laboratories (BOM:531210) Business Description

Traded in Other Exchanges
N/A
Address
Mulund Goregaon Link Road, A-101 Pratik Industrial Estate, Next to Fortis Hospital, Bhandup (West), Mumbai, MH, IND, 400078
Colinz Laboratories Ltd is an India based company engaged in manufacturing of pharmaceutical formulations. It offers formulations in the products category of ayurvedic, allopathy, and nutraceuticals. The company manufactures pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, and others. It also has certain specialized products for gynecology, cardiology, gastroenterology, and others. The group derives revenue from the sale of its products in India.

Colinz Laboratories (BOM:531210) Headlines

No Headlines